Luspatercept, a two‐edged sword in beta‐thalassemia‐associated paravertebral extramedullary hematopoietic masses (EHMs)

Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemia

(2021) Khaled M. Musallam et al.   ANNALS OF HEMATOLOGY

β-Thalassemias

(2021) Ali T. Taher et al.   NEW ENGLAND JOURNAL OF MEDICINE

Non‐transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen‐matching

(2021) Ai Leen Ang et al.   TRANSFUSION

Luspatercept Improves Quality of Life and Reduces Red Blood Cell Transfusion Burden in Patients with Non-Transfusion-Dependent β-Thalassemia in the BEYOND Trial

(2021) Antonis Kattamis et al.   BLOOD

The mechanisms of pathological extramedullary hematopoiesis in diseases

(2020) Xinxin Yang et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Smad2/3‐pathway ligand trap luspatercept enhances erythroid differentiation in murine β‐thalassaemia by increasing GATA‐1 availability

(2020) Pedro A. Martinez et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

(2020) M. Domenica Cappellini et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of non‐transfusion‐dependent β‐thalassemia ( NTDT ): The next 5 years

(2020) Khaled M. Musallam et al.   AMERICAN JOURNAL OF HEMATOLOGY

Revisiting the non‐transfusion‐dependent (NTDT) vs. transfusion‐dependent (TDT) thalassemia classification 10 years later

(2020) Khaled M. Musallam et al.   AMERICAN JOURNAL OF HEMATOLOGY

Lack of Gdf11 does not improve anemia or prevent the activity of RAP-536 in a mouse model of beta-thalassemia

(2019) Amaliris Guerra et al.   BLOOD

GDF11 is not the target of luspatercept

(2019) Clara Camaschella   BLOOD

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management

(2018) Joseph Sleiman et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Sotatercept, a novel transforming growth factor beta ligand trap, improves anemia in beta-thalassemia: a phase 2, open-label, dose-finding study

(2018) Maria Domenica Cappellini et al.   HAEMATOLOGICA

Clinical outcome of transfusions with extended red blood cell matching in β-thalassemia patients: A single-center experience

(2018) A. Belsito et al.   TRANSFUSION AND APHERESIS SCIENCE

The role of molecular typing and perfect match transfusion in sickle cell disease and thalassaemia: An innovative transfusion strategy

(2017) Rossana Putzulu et al.   TRANSFUSION AND APHERESIS SCIENCE

Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management

(2015) Elliott Vichinsky   CURRENT MEDICAL RESEARCH AND OPINION

Hydroxyurea as a first-line treatment of extramedullary hematopoiesis in patients with beta thalassemia: Four case reports

(2014) Mehran Karimi et al.   Hematology

How I treat thalassemia

(2011) E. A. Rachmilewitz et al.   BLOOD

Beta-thalassemia

(2010) Antonio Cao et al.   GENETICS IN MEDICINE